Audio Clinical Professionals

Anti-Epileptic Drug Dosing in Renal Dysfunction and Dialysis

This session reviews Anti-Epileptic Drug Dosing in Renal Dysfunction and Dialysis and its most clinically relevant points for exam preparation and bedside decision-making.

This resource is private and requires a subscriber login to stream. SIGN IN to continue.

Duration

00:02:50

File size

1.73 MB

Practitioner-Guided Note

For Anti-Epileptic Drug Dosing in Renal Dysfunction and Dialysis, focus on Topiramate: requires ~50% dose reduction; 70% renally cleared, Ethosuximide/phenobarbital: ~30% renally excreted; extend dosing interval, and Phenytoin: not removed by hemodialysis; supportive treatment for overdose when choosing therapy, counseling about risk, planning monitoring, and deciding when closer follow-up or escalation is needed.

Key Takeaways

Topiramate: requires ~50% dose reduction, 70% renally cleared; Ethosuximide/phenobarbital: ~30% renally excreted, extend dosing interval; Phenytoin: not removed by hemodialysis, supportive treatment for overdose; Uremia reduces protein binding → higher &quot,free&quot, drug fraction → toxicity at therapeutic total levels; Lamotrigine: 60% protein-bound, hemodialysis significantly drops plasma levels